XML 26 R12.htm IDEA: XBRL DOCUMENT v3.25.0.1
Note 3 - Income Taxes
12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

3.     INCOME TAXES

 

Within the calculation of the Company’s annual effective tax rate, the Company has used assumptions and estimates that may change as a result of future guidance, interpretation, and rule-making from the Internal Revenue Service, the SEC, and the FASB and/or various other taxing jurisdictions.  For example, the Company anticipates that the state jurisdictions will continue to determine and announce their conformity to the U.S. Tax Act which could have an impact on the annual effective tax rate.

 

On August 16, 2022, President Biden signed into law the Inflation Reduction Act (IRA) of 2022, which, among other things, imposes a new 15% corporate Alternative Minimum Tax (AMT) based on audited financial statement income ("AFSI") applicable to corporations with a three-year average AFSI over $1 billion. The AMT was effective starting with the 2023 tax year and, if applicable, corporations must pay the greater of the regular corporate income tax or the AMT. Although NOL carryforwards created through the regular corporate income tax system cannot be used to reduce the AMT, financial statement net operating losses can be used to reduce AFSI and the amount of AMT owed. The IRA of 2022 as enacted requires the U.S. Treasury to provide regulations and other guidance necessary to administer the AMT, including further defining allowable adjustments to determine AFSI, which directly impacts the amount of AMT to be paid. Based on interim guidance issued by the U.S. Treasury in late December 2022, the Company was not subject to the AMT in 2023 or 2024. Further, the Company believes that it is more likely than not it will not be subject to the AMT beginning 2025. The Company continues to evaluate the impacts of the Inflation Reduction Act of 2022 but does not expect this legislation to have a material impact on the Company's financial statements.

 

For tax years beginning before January 1, 2022, taxpayers can make an election with respect to research and experimental (R&E) expenditures incurred in connection with a trade or business to either currently deduct or defer and amortize such expenditures over a period of not less than 60 months. However, the Tax Cuts and Jobs Act of 2017 (TCJA) requires taxpayers to capitalize R&E expenditures effective for taxable years beginning after December 31, 2021. R&E expenditures attributable to US-based research must be amortized over a period of 5 years and R&E expenditures attributable to research conducted outside of the US must be amortized over a period of 15 years. Further, the statute provides that the definition of R&E expenditures includes amounts paid or incurred in connection with the development of any software.  The Company has recorded a deferred tax asset of $2,233 related to research and experimental expenditures for the year ending December 31, 2024.

 

The U.S. Tax Cuts and Jobs Act of 2017, or the Tax Act, imposed a mandatory transition tax on accumulated foreign earnings as of December 31, 2017 and created a new territorial tax system in which we recognize the tax impact of including certain foreign earnings in U.S. taxable income as a period cost. For the years ended December 31, 2024 and 2023, we incurred income tax expense under the global intangible low-taxed income, or GILTI, provisions and have treated it as a component of income tax expense in the period incurred.

 

The components of loss before taxes for the years ended December 31, are as follows:

 

Origin of loss before taxes

 

2024

  

2023

 

United States

 $(1,740) $(1,772)

Foreign

  (126)  303 

Loss before income taxes

 $(1,866) $(1,469)

 

Significant components of income tax expense for the years ended December 31, are as follows:

 

  

2024

  

2023

 

Current:

        

Federal

 $  $ 

State

  (51)  (19)

Foreign

  (22)  (55)

Total current

  (73)  (74)

Deferred:

        

Federal

  (2)  2 

State

  (2)  3 

Total deferred

  (4)  5 

Income tax expense

 $(77) $(69)

 

A reconciliation between the provision for income taxes calculated at the U.S. federal statutory income tax rate and the consolidated income tax expense in the consolidated statements of operations for the years ended December 31, is as follows:

 

  

2024

  

2023

 

Provision at the U.S. federal statutory rate

  21.0%  21.0%

State taxes, net of federal benefit

  4.9%  4.7%

Foreign tax rate differential

  0.2%  (0.6)%

Valuation allowance

  105.6%  (4.9)%

Chile outside basis differential

  (0.8)%  %

Italy IRES/IREP

  %  (3.8)%

Accrual to return

  2.1%  (5.8)%

Research and development credit

  11.2%  5.4%

State rate change

  0.9%  (1.4)%

Share based compensation

  (9.0)%  (6.7)%

Net Operating Loss expiration

  (144.3)%  %

Other Deferred true up

  6.4%  (6.6)%

Global Intangible Low-Taxed Income (GILTI) inclusion

  %  (4.4)%

Other

  (1.1)%  (1.7)%

Income tax expense effective rate

  (2.9)%  (4.8)%

 

The deferred tax assets and liabilities at December 31 are as follows:

 

  

2024

  

2023

 

Deferred tax assets:

        

Stock compensation expense

 $80  $250 

Royalty accruals

  10   10 

Bad debt allowance

  51   52 

Net operating loss carryforwards

  9,067   12,048 

Credit carry-forwards

  1,472   1,134 

Inventory reserve

  154   153 

Depreciation

  433   548 

Research and Development Costs

  2,233   1,053 

Other

  399   606 

Total deferred tax assets

  13,899   15,854 

Deferred tax liabilities:

        

Goodwill

  (296)  (238)

Intangible assets

  (82)  (89)

Total deferred tax liabilities

  (378)  (327)

Net deferred tax asset before valuation allowance

  13,521   15,527 

Valuation allowances for deferred tax assets

  (13,697)  (15,699)

Net deferred tax liability

 $(176) $(172)

 

The change in the valuation allowance for deferred tax assets for the years ended December 31 is as follows:

 

Year

 Balance at January 1  

Charged to costs and expenses

  (Deductions)/Other  

Balance at December 31

 

2023

 $15,627   72     $15,699 

2024

 $15,699   (2,002)    $13,697 

 

For the years ended December 31, 2024 and 2023, there were $0 and $42 exercises of stock options, respectively.

 

As required by ASC 740, we recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.

 

The table below sets forth a reconciliation of the beginning and ending amount of unrecognized tax benefit.

 

Year

 

Balance at January 1

  

Change in positions taken in a current period

  

Balance at December 31

 

2023

 $293   33  $326 

2024

 $326   144  $470 

 

If upon examination interest and penalties related to unrecognized tax benefits were assessed, they would be included in income tax expense for all periods presented. There were no interest and penalties recognized in income tax expense during the years ended December 31, 2024 and 2023. There were no unrecognized tax benefits as of December 31, 2024 and 2023. There is unrecognized tax benefit of $470 and $326 for the years ended December 31, 2024 and 2023, respectively, that would impact the future effective tax rate, if recognized.  We believe the unrecognized tax benefit will change in the next twelve months, either due to the generation or utilization of research and development credits.  We are unable to estimate the amount of change.  Tax years December 31, 2014 through December 31, 2024 remain open to assessment related to the unrecognized tax benefit.

 

We are subject to taxation in the U.S., various states, and in non-U.S. jurisdictions. Our U.S. income tax returns are primarily subject to examination from 2021 through 2023; however, U.S. tax authorities also have the ability to review prior tax years to the extent loss carryforwards and tax credit carryforwards are utilized. The open years for the non-U.S. tax returns range from 2016 through 2023 based on local statutes.

 

Management periodically estimates our probable tax obligations using historical experience in tax jurisdictions and informed judgments. There are inherent uncertainties related to the interpretation of tax regulations in the jurisdictions in which we transact business. The judgments and estimates made at a point in time may change based on the outcome of tax audits, as well as changes to or further interpretations of regulations. If such changes take place, there is a risk that the tax rate may increase or decrease in any period. Tax accruals for tax liabilities related to potential changes in judgments and estimates for both federal and state tax issues are included in current liabilities on the consolidated balance sheet.

 

The investment in foreign subsidiaries other than Fuel Tech S.p.A (Chile) and Beijing Fuel Tech is considered to be indefinite in duration and therefore we have not provided a provision for deferred U.S. income taxes on the unremitted earnings from those subsidiaries. A provision has not been established because it is not practicable to determine the amount of unrecognized deferred tax liability for such unremitted foreign earnings and because it is our present intention to reinvest the undistributed earnings indefinitely.

 

As required by ASC 740, a valuation allowance must be established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. We have approximately $27,054 of U.S. net operating loss carryforwards available to offset future U.S. taxable income as of December 31, 2024.  The net operating loss carry-forwards related to tax losses generated in years ending December 31, 2018 and before in the U.S. totaling $8,378 begin to expire in 2036.  Further, we have tax loss carry-forwards of approximately $6,459 available to offset future foreign income in Italy as of December 31, 2024. We have recorded a full valuation allowance against the deferred tax asset because we cannot anticipate when or if this entity will have taxable income sufficient to utilize the net operating losses in the future. There is no expiration of the net operating loss carry-forwards related to tax losses generated in prior years in Italy. Finally, we have tax loss carry-forwards of approximately $1,098 available to offset future foreign income in China as of December 31, 2024. 

 

As of December 31, 2019, the investment in Fuel Tech S.p.A (Chile) was no longer considered to be indefinite and a provision for deferred U.S. income taxes was recorded. As of December 31, 2023, the provision for deferred U.S. income taxes related to the Fuel Tech S.p.A (Chile) investment was $149. As of December 31, 2024, Fuel Tech S.p.A (Chile) was still included in continuing operations. As a result an additional ($13) was recorded, adjusting the total consideration to $136. The deferred income taxes associated with this investment are offset by a valuation allowance of ($136).